pSivida Corp to Present at 4th Annual Conference on Biosimilars & Biobetters
Published: Sep 27, 2013
pSivida Corp. (NASDAQ:PSDV), a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, will present at the 4th Annual Biosimilars & Biobetters Conference being held October 1 and 2 in London.
Dr. Paul Ashton, president and CEO of pSivida, will discuss “A Simple Route to Biobetters” providing delegates insight into sustained delivery of biologics. Additional case study presentations include speakers from pharmaceutical companies such as Novartis, Pfizer, Eli Lilly & Company, Roche and Merck Millipore, among others.
Help employers find you! Check out all the jobs and post your resume.